Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 10, 2026
TickeronGET DAILY SIGNALS
American Vanguard (AVD): Targeting a +23% Move Back to $1.00

American Vanguard (AVD): Targeting a +23% Move Back to $1.00

Key Takeaways

  • The central target in this article is $1.00, a realistic milestone grounded in public discussion — not an analyst-derived consensus.
  • The target is based on a psychological round-number level and the $1.00 minimum bid-price threshold that exchange listing rules center on, rather than a Wall Street price forecast.
  • At a recent price near $0.81, reaching $1.00 would require a roughly 23% advance — a modest but meaningful move for a distressed micro-cap.
  • Analyst coverage has effectively evaporated: the most recent attributable target is a stale $12.00 figure from June 2025, set before the stock's collapse, and is not a reliable guide today.
  • The strongest support for a rebound is a deeply discounted valuation (about 0.15 times book value) and ongoing restructuring, but heavy debt and covenant pressure are the dominant risks.
  • The biggest near-term threat is financial distress — roughly $284 million in total debt against a market capitalization near $24 million — plus continued demand weakness.
  • For more context on the company, explore Major News, Today's Price Move, its Forecast, and Earnings pages.

How the $1.00 Target Came Into Focus

This analysis does not rely on any manufactured consensus. Current analyst price targets for AVD are essentially unavailable, as MarketBeat shows no active consensus and the last attributable target remains the $12.00 figure from analyst Ben Klieve, which was lowered from $14.00 in June 2025. That projection is far too dated to serve as a useful forward-looking benchmark today.

As a result, the $1.00 level functions as a practical fallback drawn from broader market conversation. It represents a psychological round number the stock once traded at within its 52-week range and aligns with the minimum bid-price requirement under exchange continued-listing standards. It is not framed as an official analyst objective.

Current Market Position and the Path Ahead

AVD shares recently closed near $0.81, translating to a market capitalization of roughly $24 million. A move to $1.00 would imply about 23% upside. For a micro-cap in this situation, that distance is modest in percentage terms yet remains challenging because the stock continues in a steep downtrend, having fallen more than 80% over the past year and sitting just above its 52-week low.

The fundamental picture remains pressured. Trailing-twelve-month revenue stands near $510 million, yet the company is unprofitable with diluted EPS around -$1.91 and negative operating cash flow. In the most recent quarter, sales declined 9% year over year to about $108 million, adjusted EBITDA was roughly break-even, and full-year guidance was reduced.

Factors That Could Support a Rebound

Several elements could help push the stock toward $1.00. The valuation sits at an extremely depressed level, with shares trading near 0.15 times book value per share of about $6.27, suggesting the market is pricing in significant distress rather than any modest recovery. Management continues to execute a restructuring and transformation plan focused on cost cuts, inventory management, and new product introductions, with a longer-term aim of surpassing $600 million in revenue. Customer prepayments and working-capital efforts have strengthened near-term cash, and the company has reaffirmed its goal of lowering leverage as it receives prepayments during the seasonally stronger fourth quarter. Even modest stabilization in demand and margin improvement could shift sentiment from such a low base. I also checked this using Tickeron’s AI Daily Buy/Sell Signals to monitor any early shifts in momentum.

Risks That Could Block the Target

The obstacles remain considerable. AVD carries roughly $284 million in total debt against a market value near $24 million, with management reporting a gross leverage ratio of about 6.5 times — uncomfortably close to the covenant limit of 6.7 times. Persistent softness in international markets, rising freight and raw-material costs, and weaker crop-protection volumes continue to weigh on results. Further earnings pressure or a covenant breach could lead to refinancing needs, dilution, or additional valuation compression. The stock’s drop below $1.00 also raises listing-compliance issues that might trigger a reverse split, which frequently adds selling pressure.

Technical Levels Worth Watching

The technical setup is weak but offers clear reference points. The 50-day moving average sits near $1.66 and the 200-day moving average near $2.78, both well above the current price and serving as overhead resistance. The 52-week range runs from roughly $0.81 to $5.55. The $1.00 level stands as the first meaningful psychological and regulatory milestone on any recovery path, while the prior support-turned-resistance zone above $1.00 may prove difficult to reclaim without a clear fundamental catalyst.

Time Horizon and Key Items to Monitor

With no current analyst price targets available, there is no standard 12-month research window tied to this objective. Investors should instead view $1.00 as a near-to-intermediate milestone. Important areas to track include quarterly earnings and adjusted EBITDA, any revisions to full-year guidance, leverage and debt-covenant updates, international sales trends especially in Latin America, and any statements on listing compliance or a possible reverse split. Freight costs, raw-material expenses, and traction on new products will also serve as useful indicators.

Using AI Tools in My Research Process

In my own analysis of names like AVD, I often rely on Tickeron’s AI Daily Buy/Sell Signals to scan for shifting patterns across thousands of securities. These AI-driven signals help highlight potential entry or exit points based on technical and market-condition changes, which can be especially useful for volatile, low-priced stocks where manual monitoring alone can miss subtle developments. The tool has become a regular part of how I cross-check ideas before forming a view.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AVD

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


AVD's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for AVD turned positive on October 28, 2026. Looking at past instances where AVD's MACD turned positive, the stock continued to rise in 33 of 47 cases over the following month. The odds of a continued upward trend are 70%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +6.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where AVD advanced for three days, in 189 of 287 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

AVD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AVD as a result. In 72 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.

The Aroon Indicator for AVD entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 10 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.157) is normal, around the industry mean (-0.492). P/E Ratio (-0.504) is within average values for comparable stocks, (8.794). Projected Growth (PEG Ratio) (0.390) is also within normal values, averaging (0.867). Dividend Yield (0.125) settles around the average of (0.126) among similar stocks. AVD's P/S Ratio (0.119) is slightly lower than the industry average of (1.476).

The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. AVD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.

Notable companies

The most notable companies in this group are CF Industries Holding (NYSE:CF), Mosaic Company (The) (NYSE:MOS).

Industry description

The agricultural chemicals sector includes companies that produce chemical products for the agricultural industry applications like crop protection, animal health, biotechnology and pharmaceutical-related products. Some of the largest agricultural chemicals producers include Nutrien Ltd., Corteva Inc., and FMC Corporation.

Market Cap

The average market capitalization across the Chemicals: Agricultural Industry is 6.12B. The market cap for tickers in the group ranges from 611 to 34.11B. NTR holds the highest valuation in this group at 34.11B. The lowest valued company is BHILQ at 611.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Agricultural Industry was 27%. For the same Industry, the average monthly price growth was 9%, and the average quarterly price growth was -16%. MOS experienced the highest price growth at 20%, while AVD experienced the biggest fall at -25%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Agricultural Industry was -5%. For the same stocks of the Industry, the average monthly volume growth was -25% and the average quarterly volume growth was 2%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 36
P/E Growth Rating: 50
Price Growth Rating: 60
SMR Rating: 80
Profit Risk Rating: 78
Seasonality Score: -25 (-100 ... +100)
AI Screener 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of a diverse group of agricultural products

Industry ChemicalsAgricultural

Industry
Chemicals Agricultural
Address
4695 MacArthur Court
Phone
+1 949 260-1200
Employees
739
Web
https://www.american-vanguard.com
Interact to see
Advertisement
AtlasClear Holdings (ATCH) shares fell roughly 25.5% over the last 30 days, declining from $0.1881 on October 2 to $0.1401 on October 30. The pullback extended a longer downtrend that has kept the stock trading well below the $1.00 NYSE American minimum, keeping continued listing-compliance risk in focus.
XRPN fell -9.70% in early regular-session trading on Tuesday, sliding from Monday's $10.41 close to $9.40. The decline follows a November 9 SEC prospectus disclosing a committed equity facility with Cantor to sell up to 5.2 million new Class A shares at 97% of the volume-weighted average price, implying up to roughly 16.7% potential dilution.
CCAP climbed +7.03% during regular market hours, rising from a prior close of $9.24 to $9.89. The rally followed its Q3 2026 report: net investment income of $0.37/share beat the $0.35 consensus and revenue of $36.9M topped estimates, alongside a new $50M buyback authorization plus up to $25M in additional Sun Life purchases.
NVDA fell -2.10% to $216.66 during regular trading, down from a prior close of $221.30. Primary catalyst: hotter-than-expected September CPI data reignited Fed rate-hike fears, raising borrowing costs for AI infrastructure buildouts.
NVDA dropped from Friday's close of $186.64 to $174.06 intraday, down -6.74%, during regular market hours. The slide followed CEO Jensen Huang's admission of an extramarital affair and the board's independent investigation, announced November 8, after reports he was targeted by a suspected Chinese intelligence operative.